Clinical Trial Results: A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating oral etrasimod for moderately to severely active Crohn's disease has completed phases 2 and 3 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Crohn's Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2026-07-01